Germ-line mutations at BRCA1 in northeastern France;Mutations germinales du gene BRCA1 dans le Nord-Est de la France

Bulletin du Cancer

Volumn 87, Issue 10, 2000, Pages 739-744

  Fricker, J P ^a   Muller, D ^a   Cutuli, B ^a   Rodier, J F ^a   Janser, J C ^a   Jung, G M ^a   Mors, R ^a   Petit, T ^a   Haegele, P ^a   Abecassis, J ^a  

^a Paul Strauss Comprehensive Cancer Center   (France)

Author keywords

BRCA1 gene; Breast cancer; Frequent mutations; Genetic susceptibility; Ovarian cancer

Indexed keywords

BRCA1 PROTEIN;

ARTICLE; BREAST CANCER; DISEASE CARRIER; EXON; FEMALE; FRANCE; GENE MUTATION; GENETIC ANALYSIS; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GERM LINE; HUMAN; ONCOGENE; OVARY CANCER; STOP CODON; ADULT; AGE; BREAST TUMOR; DNA SEQUENCE; FAMILIAL CANCER; GENETICS; MALE; METHODOLOGY; MIDDLE AGED; MUTATION; OVARY TUMOR; TUMOR SUPPRESSOR GENE;

ADULT; AGE FACTORS; BREAST NEOPLASMS; BREAST NEOPLASMS, MALE; FEMALE; FRANCE; GENES, BRCA1; GERM-LINE MUTATION; HUMANS; MALE; MIDDLE AGED; NEOPLASTIC SYNDROMES, HEREDITARY; OVARIAN NEOPLASMS; SEQUENCE ANALYSIS, DNA;

EID: 0034293136     PISSN: 00074551     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Linkage of early-onset familial breast cancer to chromosome 17q21
2. Familial breast-ovarian cancer locus on chromosome 17q12-q23
3. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1
4. BRCA1, BRCA2 and their possible function in DNA damage response
5. Growth retardation and tumour inhibition by BRCA1
6. Antisense RNA to the putative tumor suppressor gene BRCA1 transforms mouse fibroblasts
7. Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13
8. Identification of the breast cancer susceptibility gene BRCA2
9. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium
10. Mutations and polymorphisms in the familial early-onset breast cancer (BRCA1) gene. Breast Cancer Information Core
11. Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium
12. Ethnic differences in cancer risk resulting from genetic variation
13. An evaluation of genetic heterogeneity in 145 breast-ovarian cancer families. Breast Cancer Linkage Consortium
14. Population genetics of BRCA1 and BRCA2
15. Founder BRCA1 and BRCA2 mutations in Ashkenazi Jews in Israel: Frequency and differential penetrance in ovarian cancer and in breast-ovarian cancer families
16. A single BRCA2 mutation in male and female breast cancer families from Iceland with varied cancer phenotypes
17. Recurrent BRCA2 6174delT mutations in Ashkenazi Jewish women affected by breast cancer
18. Segregation of two BRCA1 mutations in a single family
19. The cancer-predisposing mutation C61G disrupts homodimer formation in the NH2-terminal BRCA1 RING finger domain
20. Comparison of BRCA1 polymorphism, rare sequence variants and/or missense mutations in unaffected and breast/ovarian cancer populations
21. Germ-line mutation of BRCA1 in patients with breast and/or ovarian cancer in high risk families in Northern France
22. BRCA1 sequence variations in 160 individuals referred to a breast/ovarian family cancer clinic. Institut Curie Breast Cancer Group
23. The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals
24. A high proportion of novel mutations in BRCA1 with strong founder effects among Dutch and Belgian hereditary breast and ovarian cancer families
25. BRCA1 and BRCA2 in breast cancer families from Wales: Moderate mutation frequency and two recurrent mutations in BRCA1
26. Founding BRCA1 mutations in hereditary breast and ovarian cancer in southern Sweden
27. BRCA1 mutations in southern England
28. Frequency of BRCA1 mutation 5382insC in German breast cancer patients
29. Common origins of BRCA1 mutations in Canadian breast and ovarian cancer families
30. Founder BRCA1 and BRCA2 mutations in French Canadian breast and ovarian cancer families
31. Sequence analysis of BRCA1 and BRCA2: Correlation of mutations with family history and ovarian cancer risk
32. Haplotype and phenotype analysis of six recurrent BRCA1 mutations in 61 families: Results of an international study
33. Survival and tumour characteristics of breastcancer patients with germline mutations of BRCA1
34. Recommendations for medical management of hereditary breast and ovarian cancer: The French National Ad Hoc Committee
35. Risques hereditaires des cancers du sein et de l'ovaire Expertise collective Inserm/FNCLCC Paris: Editions Inserm
36. Germ line mutation at BRCA1 affects the histoprognostic grade in hereditary breast cancer
37. BRCA1 and BRCA2 hereditary breast carcinoma phenotypes
38. Low frequency of lymph-node metastasis in BRCA1-associated breast cancer
39. BRCA1 and BRCA2 hereditary breast carcinoma phenotypes
40. Survival of BRCA1 breast and ovarian cancer patients: A population-based study from southern Sweden
41. Germline mutations of the BRCA1 gene in breast and ovarian cancer families provide evidence for a genotype-phenotype correlation
42. A collaborative survey of 80 mutations in the BRCA1 breast and ovarian cancer susceptibility gene. Implications for presymptomatic testing and screening
43. BRCA1 genomic deletions are major founder mutations in Dutch breast cancer patients
44. Screening for germ-line rearrangements and regulatory mutations in BRCA1 led to the identification of four new deletions
45. Isolation of DNA from blood
46. Rapid detection of BRCA1 mutations by the protein truncation test